SCHEMBL10849656

SCHEMBL10849656

CC(NCC1=CCOc2ccccc21)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
CASR P41180 3/20 0.40
CYP3A4 P08684 2/20 0.40
LMNA P02545 2/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
SMPD1 P17405 1/20 0.40
DRD1 P21728 1/20 0.40
TBXA2R P21731 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10853398 0.83 CASR (0.48) MEN1KMT2AHTTSMN1; SMN2CASR
SCHEMBL10851543 0.79 BCHE (0.44) MEN1KMT2AHTTSMN1; SMN2CYP1A2
SCHEMBL9768795 0.77 HTR7 (0.35) MEN1KMT2ACYP3A4LMNACHRM2
SCHEMBL10849315 0.77 MEN1 (0.42) MEN1KMT2AHTTSMN1; SMN2CASR
SCHEMBL16263333 0.74 PKM (0.35) MEN1KMT2A
SCHEMBL10855574 0.74 HTT (0.43) MEN1KMT2AHTTSMN1; SMN2CASR
SCHEMBL10854824 0.74 ESR1 (0.36) MEN1KMT2ACHRM2CHRM1SLC6A4
SCHEMBL10849661 0.70 GAA (0.47) CYP3A4CHRM2CHRM1CYP2D6CYP2C19
SCHEMBL295321 0.69 PKM (0.38) KMT2AHTTSMN1; SMN2LMNA
SCHEMBL9768971 0.69 PKM (0.38) KMT2AHTTSMN1; SMN2LMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4563458-A CIRCULATORY SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1986-01-07 US disclosed
EP-0114374-A1 Substituted 4-aminomethylene chromans or chromenes, process for their preparation and their use in medicines BAYER AG (DE) 1984-08-01 EP disclosed